New tool could help spot brain issues in At-Risk newborns earlier

NCT ID NCT07182513

First seen Jun 25, 2026 · Last updated Jul 15, 2026 · Updated 3 times

Summary

This study is translating and testing a Turkish version of the Hammersmith Neonatal Neurological Examination (HNNE) for high-risk infants, such as premature babies or those with birth complications. Researchers will check if the exam is reliable and valid for use in Turkey by comparing scores from 120 infants. The goal is to give doctors a better way to catch early signs of cerebral palsy and other developmental problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could provide Turkish healthcare professionals with a reliable tool to detect neurological problems early in high-risk infants, potentially improving outcomes through timely intervention.
What could go wrong
This is an observational validation study, not a treatment trial. It will not directly improve health, and the tool may not predict long-term outcomes as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL PALSY (CP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kahramanmaraş Sütçü imam University

    Kahramanmaraş, Onikişubat, 46100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.